Home - Products - Angiogenesis - CDK - Abemaciclib metabolite M20

Abemaciclib metabolite M20

CAS No. 2138499-06-4

Abemaciclib metabolite M20( CDK4/6-IN-4 | LSN3106726 )

Catalog No. M26100 CAS No. 2138499-06-4

Abemaciclib metabolite M20 is an active metabolite of Abemaciclib.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 217 In Stock
10MG 345 In Stock
25MG 588 In Stock
50MG 799 In Stock
100MG 1097 In Stock
200MG Get Quote In Stock
500MG 2204 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Abemaciclib metabolite M20
  • Note
    Research use only, not for human use.
  • Brief Description
    Abemaciclib metabolite M20 is an active metabolite of Abemaciclib.
  • Description
    Abemaciclib metabolite M20 is an active metabolite of Abemaciclib. Abemaciclib metabolite M20 is a selective CDK4/6 inhibitor and can be used for researches on the treatment of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    CDK4/6-IN-4 | LSN3106726
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    PEGs
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2138499-06-4
  • Formula Weight
    522.605
  • Molecular Formula
    C27H32F2N8O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (9.57 mM)
  • SMILES
    CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)-c3cc(F)c4nc(CO)n(C(C)C)c4c3)nc2)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
molnova catalog
related products
  • CCT-251921

    A potent, selective, and orally bioavailable inhibitor of CDK8 and CDK19 with IC50of 2.3 nM and 2.6 nM respectively.

  • BSJ-4-116

    BSJ-4-116 is a highly potent and selective CDK12 degrader (PROTAC) with an IC50 of 6 nM.?It downregulates DDR genes through a premature termination of transcription, primarily through increasing poly(adenylation).

  • NG-52

    NG 52 (Compound 52 ) is a potent, cell-permeable, reversible, selective, and ATP-compatible inhibitor of the cell cycle-regulating kinase.